The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EHC | +12.82% | +109.38% | +15.91% | +3,185% |
| S&P | +13.19% | +87.83% | +13.42% | +2,750% |
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.48B | 9.4% |
| Gross Profit | $299.70M | 13.9% |
| Gross Margin | 20.28% | 0.8% |
| Market Cap | $12.79B | 31.6% |
| Market Cap / Employee | $0.32M | 0.0% |
| Employees | 40K | 5.9% |
| Net Income | $174.70M | 18.8% |
| EBITDA | $326.00M | 13.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $93.70M | -52.9% |
| Accounts Receivable | $610.80M | 6.0% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.60B | 2.2% |
| Short Term Debt | $64.90M | -75.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 8.11% | 1.2% |
| Return On Invested Capital | 7.02% | 0.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $83.70M | -30.4% |
| Operating Free Cash Flow | $270.80M | 1.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 20.70 | 20.91 | 23.98 | 24.01 | 2.89% |
| Price to Book | 4.75 | 4.94 | 5.73 | 5.62 | 6.24% |
| Price to Sales | 1.76 | 1.88 | 2.21 | 2.24 | 18.50% |
| Price to Tangible Book Value | 24.52 | 21.04 | 21.31 | 18.81 | -51.20% |
| Price to Free Cash Flow TTM | 31.76 | 32.16 | 33.71 | 38.96 | -21.85% |
| Enterprise Value to EBITDA | 41.19 | 39.44 | 46.81 | 50.12 | 9.23% |
| Free Cash Flow Yield | 3.1% | 3.1% | 3.0% | 2.6% | 27.96% |
| Return on Equity | 24.5% | 25.3% | 25.3% | 24.9% | 1.68% |
| Total Debt | $2.71B | $2.70B | $2.69B | $2.66B | -4.93% |
No podcast episodes available.
EHC earnings call for the period ending September 30, 2021.
EHC earnings call for the period ending June 30, 2021.
EHC earnings call for the period ending March 31, 2021.
EHC earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
